Compare EYPT & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EYPT | DFIN |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Other Consumer Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2005 | N/A |
| Metric | EYPT | DFIN |
|---|---|---|
| Price | $18.26 | $46.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $29.60 | ★ $63.50 |
| AVG Volume (30 Days) | ★ 1.3M | 293.1K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.12 |
| Revenue | $42,339,000.00 | ★ $750,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.20 |
| P/E Ratio | ★ N/A | $41.32 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.91 | $37.80 |
| 52 Week High | $19.11 | $69.93 |
| Indicator | EYPT | DFIN |
|---|---|---|
| Relative Strength Index (RSI) | 66.55 | 48.10 |
| Support Level | $16.52 | $45.72 |
| Resistance Level | $19.00 | $47.19 |
| Average True Range (ATR) | 1.04 | 1.26 |
| MACD | 0.10 | 0.12 |
| Stochastic Oscillator | 74.24 | 60.88 |
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.